Atlantic Street Capital Announces Acquisition of Brown’s Medical Imaging | To Combine with Prestige Medical Imaging, to Establish the No.2 Presence Nationally in Medical Imaging Distribution

Atlantic Street Capital (“ASC”), a private equity firm targeting entrepreneurial businesses poised for the next level of growth, acquired Brown’s Medical Imaging, the largest independent medical imaging service and solutions provider in the Midwest United States. ASC previously acquired Prestige Medical Imaging (PMI), a leading provider of imaging service and solutions serving the eastern half of the U.S., in 2021.

Founded in 1995 and headquartered in Omaha, NE, Brown’s Medical Imaging is a medical imaging solutions company providing equipment, service, maintenance, services and support to hospitals, physician practices and ambulatory service centers across the Midwest. Key products include a broad suite of medical imaging equipment including X-ray machines, mammography systems, CT scanners, ultrasound machines, MRI systems, and surgical C-arm systems. Customer practice specialties include orthopedics, radiology, pulmonology, veterinary, chiropractic, urology, podiatry, and urgent care centers.

Peter Shabecoff, Managing Partner of ASC, and deal lead said, “Brown’s Medical Imaging is a service-first organization, differentiating itself against competitors that are positioned as sales-first. Brown’s offers deep and differentiated service coverage, providing the flexibility that national competitors are unable to provide, and servicing its customers at the local level. Brown’s are seen as partners, rather than product and service providers. We are excited to begin working with Chad and the team to broaden the company’s geographic footprint and identify select acquisitions to enhance its suite of product and service offerings. The partnership of Brown’s and Prestige will be a national market leader; the combined companies will be uniquely positioned to serve customers across geographies and imaging modalities.”

Chad Brown, President of Brown’s Medical Imaging, commented, “Our business was founded on the basis of providing the highest level of expert service to our local customers – irrespective of size; and for over 28 years we have lived up to that purpose. With the added support of Atlantic Street Capital, who have invested in businesses similar to ours, we will continue to grow while delivering best-in-class radiology solutions and services to new and existing customers.”

Chad will continue to lead the Brown’s business, and with the other key members of the senior management team, has maintained a meaningful ownership position in the business. The team will also work closely with newly appointed ASC Medical Imaging Platform CEO, Larry Hicks, to collaborate, and eventually combine with PMI, to optimize service and sales across a wider geography, modalities, and vendor base.

Hicks commented, “We will ultimately bring PMI and Brown’s together at the appropriate time to create the 2nd largest independent provider of medical imaging service and solutions in the US. In the meantime, we will collaborate to identify key learnings that allow us to provide higher quality service for our customers and optimize our territorial service delivery for efficiency. I am looking forward to working with the talented teams at Brown’s and PMI moving forward.”

ASC’s expertise in the healthcare services sector includes its investments in Renew Digital, a leading provider of refurbished dental imaging equipment and services, as well, it’s proprietary Global Surgical dental microscope business (the leading dental microscope brand in the U.S.); Prescott’s, the leading independent provider of refurbishment, maintenance, repair, and service work for surgical microscopes in both the U.S. and the UK, utilized in hospital operating rooms and ambulatory surgery centers; Aligned Orthopedic, the premier provider of orthopedic services in the greater Washington, D.C. region; BioTouch, a leading provider of mission critical, transportation solutions exclusively focused on the medical laboratory and hospital industry; and Anatomy IT, the leading provider of managed IT services to the healthcare industry in the Eastern United States.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”